GLOW

Community reports

Skin & beauty

The cosmetic-first cousin of KLOW — three peptides aimed at skin and recovery, weighted toward GHK-Cu.

What it is

GLOW is a compounded blend of three peptides — GHK-Cu, BPC-157, and TB-500 — with GHK-Cu dominant, typically in a 50:10:10 ratio. Unlike KLOW, it leaves out the gut peptide and leans into skin and post-procedure recovery. No FDA approval and no controlled trials on the blend itself.

How it works

GHK-Cu carries the cosmetic story — collagen and elastin stimulation plus its famous gene-expression effects. BPC-157 contributes blood-vessel growth and tendon support, while TB-500 adds cell migration and tissue remodeling. In theory it covers the structural, cellular, and mechanical sides of skin at once.

What people report

✦Post-laser, post-microneedling, and post-peel recovery
✦Skin-quality improvements within 6-8 weeks in many users
✦Hair density when paired with scalp microneedling
✦Described as 'GHK-Cu plus' by many who've tried both

Typical use

Typically a daily or near-daily injection run for several weeks, mirroring other healing-protocol patterns.

Dosing reference

No standard — ratios (50/10/10, 35/10/5) and totals vary across vendors.

Reference only — not a recommendation. Verify via primary sources.

Watch for

GHK-Cu is doing most of the work, and it has real evidence behind it; BPC-157 and TB-500 broaden the use case rather than raise the bar. There's no head-to-head against GHK-Cu alone, and several users report the added benefit is hard to perceive.

Notes

Same compounding regulatory shadow as KLOW — the ingredient with genuine evidence is the one doing the heavy lifting.

Understand the full reconstitution process →

Educational content — not medical advice.